Table 2.

Baseline inflammatory markers, median (IQR), stratified by potential predictorsa

VariableNCRP (mg/dL)IL-6 (pg/mL)sTNF-R2 (pg/mL)IL-10 (pg/mL)
25(OH)D <20 ng/mL2152.61 (0.89–4.49)b2.38 (1.32–3.83)c2031.4 (1687.7–2460.8)c0.53 (0.46–0.67)c
25(OH)D ≥20 ng/mL1131.68 (0.48–4.19)b2.10 (1.16–3.88)c2139.0 (1732.8–2610.0)c0.52 (0.46–0.63)c
BMId <30 kg/m21461.19 (0.38–2.74)b1.68 (0.99–2.73)b1882.8 (1585.1–2316.5)b0.52 (0.46–0.65)c
BMId ≥30 kg/m21823.84 (1.51–7.21)b3.00 (1.78–4.62)b2186.7 (1815.7–2721.7)b0.53 (0.46–0.65)c
Smoker992.76 (0.87–5.51)c2.30 (1.60–4.17)c2047.3 (1763.1–2728.6)c0.52 (0.45–0.64)c
Nonsmoker2232.07 (0.67–4.88)c2.30 (1.17–3.81)c2045.9 (1658.5–2481.3)c0.53 (0.46–0.65)c
  • aP value calculated using the Kruskal–Wallis test.

  • bP < 0.0001.

  • cP > 0.05.

  • dBMI missing for 3 patients.